Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Carducci

Showing results (51-60 of 322) with videos related to

Pageof 33
Sort By:
Investigational New Drugs|June 22, 2006
A Phase I study of the oral antimetabolite, CS-682, administered once daily 5 days per week in patients with refractory solid tumor malignanciesJill Gilbert, Michael A Carducci, Sharyn D Baker, et al.
Archives of Internal Medicine|March 29, 2007
Relation between duration of androgen deprivation therapy and degree of insulin resistance in men with prostate cancerShehzad Basaria, Denis C Muller, Michael A Carducci, et al.
Cancer|January 3, 2006
Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapyShehzad Basaria, Denis C Muller, Michael A Carducci, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 29, 2010
Relevant content for a patient-reported outcomes questionnaire for use in oncology clinical practice: Putting doctors and patients on the same pageClaire F Snyder, Roxanne E Jensen, Gail Geller, et al.
Urology|December 9, 2009
Recent time trends in the epidemiology of stage IV prostate cancer in the United States: analysis of data from the Surveillance, Epidemiology, and End Results ProgramKarynsa Cetin, Jennifer L Beebe-Dimmer, Jon P Fryzek, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 6, 2011
Progression of prostate carcinogenesis and dietary methyl donors: temporal dependenceShabana Shabbeer, Simon A Williams, Brian W Simons, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2010
Castration-dependent pharmacokinetics of docetaxel in patients with prostate cancerRyan M Franke, Michael A Carducci, Michelle A Rudek, et al.
Analytical Biochemistry|December 24, 2003
Simultaneous analysis of docetaxel and the formulation vehicle polysorbate 80 in human plasma by liquid chromatography/tandem mass spectrometrySharyn D Baker, Ming Zhao, Ping He, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 21, 2021
End-of-Life Characteristics Associated With Short Hospice Length of Stay for Patients With Solid Tumors Enrolled in Phase I Clinical TrialsRamy Sedhom, Amanda L Blackford, Arjun Gupta, et al.
The Prostate|May 7, 2019
Risk of development of visceral metastases subsequent to abiraterone vs placebo: An analysis of mode of radiographic progression in COU-AA-302Benjamin A Teply, Fang Qiu, Emmanuel S Antonarakis, et al.
Pageof 33

Showing results (51-60 of 322) with videos related to

Sort By:
Pageof 33
Investigational New Drugs|June 22, 2006
A Phase I study of the oral antimetabolite, CS-682, administered once daily 5 days per week in patients with refractory solid tumor malignanciesJill Gilbert, Michael A Carducci, Sharyn D Baker, et al.
Archives of Internal Medicine|March 29, 2007
Relation between duration of androgen deprivation therapy and degree of insulin resistance in men with prostate cancerShehzad Basaria, Denis C Muller, Michael A Carducci, et al.
Cancer|January 3, 2006
Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapyShehzad Basaria, Denis C Muller, Michael A Carducci, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 29, 2010
Relevant content for a patient-reported outcomes questionnaire for use in oncology clinical practice: Putting doctors and patients on the same pageClaire F Snyder, Roxanne E Jensen, Gail Geller, et al.
Urology|December 9, 2009
Recent time trends in the epidemiology of stage IV prostate cancer in the United States: analysis of data from the Surveillance, Epidemiology, and End Results ProgramKarynsa Cetin, Jennifer L Beebe-Dimmer, Jon P Fryzek, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 6, 2011
Progression of prostate carcinogenesis and dietary methyl donors: temporal dependenceShabana Shabbeer, Simon A Williams, Brian W Simons, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2010
Castration-dependent pharmacokinetics of docetaxel in patients with prostate cancerRyan M Franke, Michael A Carducci, Michelle A Rudek, et al.
Analytical Biochemistry|December 24, 2003
Simultaneous analysis of docetaxel and the formulation vehicle polysorbate 80 in human plasma by liquid chromatography/tandem mass spectrometrySharyn D Baker, Ming Zhao, Ping He, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 21, 2021
End-of-Life Characteristics Associated With Short Hospice Length of Stay for Patients With Solid Tumors Enrolled in Phase I Clinical TrialsRamy Sedhom, Amanda L Blackford, Arjun Gupta, et al.
The Prostate|May 7, 2019
Risk of development of visceral metastases subsequent to abiraterone vs placebo: An analysis of mode of radiographic progression in COU-AA-302Benjamin A Teply, Fang Qiu, Emmanuel S Antonarakis, et al.
Pageof 33